Nextage Therapeutics (XTAE:NXTG) FCF Yield % : -8.15 (As of May. 06, 2024)

View and export this data going back to 1993. Start your Free Trial

What is Nextage Therapeutics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Nextage Therapeutics's Trailing 12-Month Free Cash Flow is ₪-2.26 Mil, and Market Cap is ₪27.75 Mil. Therefore, Nextage Therapeutics's FCF Yield % for today is -8.15%.

The historical rank and industry rank for Nextage Therapeutics's FCF Yield % or its related term are showing as below:

XTAE:NXTG' s FCF Yield % Range Over the Past 10 Years
Min: -122.08 Med: -45.7 Max: -5.72
Current: -8.15

During the past 8 years, the highest FCF Yield % of Nextage Therapeutics was -5.72%. The lowest was -122.08%. And the median was -45.70%.

XTAE:NXTG's FCF Yield % is ranked worse than
73.24% of 1080 companies
in the Drug Manufacturers industry
Industry Median: -0.625 vs XTAE:NXTG: -8.15

Nextage Therapeutics's FCF Margin % for the quarter that ended in Dec. 2023 was -44.60%.

Nextage Therapeutics FCF Yield % Historical Data

The historical data trend for Nextage Therapeutics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nextage Therapeutics FCF Yield % Chart

Nextage Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-24.28

-8.07

-6.88

-36.88

-22.31

Nextage Therapeutics Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial									-5.37	-21.54	-31.53	-18.57	-6.27

Competitive Comparison of Nextage Therapeutics's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Nextage Therapeutics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nextage Therapeutics's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Nextage Therapeutics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Nextage Therapeutics's FCF Yield % falls into.

Nextage Therapeutics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Nextage Therapeutics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-2.262	/	10.139981
	=	-22.31%

Nextage Therapeutics's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.318	*	2	/	10.139981
	=	-6.27%

Nextage Therapeutics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Nextage Therapeutics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Nextage Therapeutics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Nextage Therapeutics (XTAE:NXTG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nextage Therapeutics Ltd (XTAE:NXTG) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bio-Light, Kiryat Atidim 7, Entrance 1, 2rd Floor, Tel Aviv, ISR, 61581

Website

http://www.m-medic.com

Nextage Therapeutics Ltd is a holding company. The company, through its subsidiaries, is engaged in the development of biological marker, a molecule/gene, which when present in the body at abnormal levels indicates development of a disease. It is focused on the development and commercialization of cancer diagnostic products.

Nextage Therapeutics (XTAE:NXTG) Headlines

From GuruFocus

First Trust Global Portfolios Limited Announces Name Changes for Certain Sub-Funds of First Trust Global Funds plc

By Business Wire Business Wire • 01-29-2021